These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37796613)

  • 1. Risk Factors for Chronic Obstructive Pulmonary Disease Exacerbations among Individuals without a History of Recent Exacerbations: A COPDGene Analysis.
    Ferrera MC; Lopez CL; Murray S; Jain RG; Labaki WW; Make BJ; Han MK
    Ann Am Thorac Soc; 2024 Mar; 21(3):421-427. PubMed ID: 37796613
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
    Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
    Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
    Han MK; Quibrera PM; Carretta EE; Barr RG; Bleecker ER; Bowler RP; Cooper CB; Comellas A; Couper DJ; Curtis JL; Criner G; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Krishnan JA; Martinez CH; Pirozzi CB; O'Neal WK; Rennard S; Tashkin DP; Wedzicha JA; Woodruff P; Paine R; Martinez FJ;
    Lancet Respir Med; 2017 Aug; 5(8):619-626. PubMed ID: 28668356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting exacerbations in COPD in the Danish general population.
    Marott JL; Ingebrigtsen TS; Çolak Y; Vestbo J; Nordestgaard BG; Lange P
    Respir Med; 2024 Apr; 224():107557. PubMed ID: 38355020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD.
    Baumeler L; Papakonstantinou E; Milenkovic B; Lacoma A; Louis R; Aerts JG; Welte T; Kostikas K; Blasi F; Boersma W; Torres A; Rohde GG; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D
    Respirology; 2016 Jul; 21(5):883-90. PubMed ID: 26970108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers Predictive of Exacerbations in the SPIROMICS and COPDGene Cohorts.
    Keene JD; Jacobson S; Kechris K; Kinney GL; Foreman MG; Doerschuk CM; Make BJ; Curtis JL; Rennard SI; Barr RG; Bleecker ER; Kanner RE; Kleerup EC; Hansel NN; Woodruff PG; Han MK; Paine R; Martinez FJ; Bowler RP; O'Neal WK;
    Am J Respir Crit Care Med; 2017 Feb; 195(4):473-481. PubMed ID: 27579823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting severe chronic obstructive pulmonary disease exacerbations using quantitative CT: a retrospective model development and external validation study.
    Chaudhary MFA; Hoffman EA; Guo J; Comellas AP; Newell JD; Nagpal P; Fortis S; Christensen GE; Gerard SE; Pan Y; Wang D; Abtin F; Barjaktarevic IZ; Barr RG; Bhatt SP; Bodduluri S; Cooper CB; Gravens-Mueller L; Han MK; Kazerooni EA; Martinez FJ; Menchaca MG; Ortega VE; Iii RP; Schroeder JD; Woodruff PG; Reinhardt JM
    Lancet Digit Health; 2023 Feb; 5(2):e83-e92. PubMed ID: 36707189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phenotype of concurrent chronic bronchitis and frequent exacerbations in patients with severe COPD attending Swedish secondary care units.
    Sundh J; Johansson G; Larsson K; Lindén A; Löfdahl CG; Sandström T; Janson C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2327-34. PubMed ID: 26604732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of gastroesophageal reflux disease risk with exacerbations of chronic obstructive pulmonary disease.
    Liang B; Wang M; Yi Q; Feng Y
    Dis Esophagus; 2013 Aug; 26(6):557-60. PubMed ID: 23301861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
    Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
    Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of gastroesophageal reflux on longitudinal lung function and quantitative computed tomography in the COPDGene cohort.
    Baldomero AK; Wendt CH; Petersen A; Gaeckle NT; Han MK; Kunisaki KM;
    Respir Res; 2020 Aug; 21(1):203. PubMed ID: 32746820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent and Newly Developed Chronic Bronchitis Are Associated with Worse Outcomes in Chronic Obstructive Pulmonary Disease.
    Kim V; Zhao H; Boriek AM; Anzueto A; Soler X; Bhatt SP; Rennard SI; Wise R; Comellas A; Ramsdell JW; Kinney GL; Han MK; Martinez CH; Yen A; Black-Shinn J; Porszasz J; Criner GJ; Hanania NA; Sharafkhaneh A; Crapo JD; Make BJ; Silverman EK; Curtis JL;
    Ann Am Thorac Soc; 2016 Jul; 13(7):1016-25. PubMed ID: 27158740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.
    Fraser A; Poole P
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013343. PubMed ID: 36373977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of comorbidities in COPD clinical control criteria. The CLAVE study.
    Almagro P; Soler-Cataluña JJ; Huerta A; González-Segura D; Cosío BG;
    BMC Pulm Med; 2024 Jan; 24(1):6. PubMed ID: 38166965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.
    Han MK; Muellerova H; Curran-Everett D; Dransfield MT; Washko GR; Regan EA; Bowler RP; Beaty TH; Hokanson JE; Lynch DA; Jones PW; Anzueto A; Martinez FJ; Crapo JD; Silverman EK; Make BJ
    Lancet Respir Med; 2013 Mar; 1(1):43-50. PubMed ID: 24321803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical prediction model for hospitalized COPD exacerbations based on "treatable traits".
    Yii ACA; Loh CH; Tiew PY; Xu H; Taha AAM; Koh J; Tan J; Lapperre TS; Anzueto A; Tee AKH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():719-728. PubMed ID: 30988606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examining the Effects of Age on Health Outcomes of Chronic Obstructive Pulmonary Disease: Results From the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease Study and Evaluation of Chronic Obstructive Pulmonary Disease Longitudinally to Identify Predictive Surrogate Endpoints Cohorts.
    Parulekar AD; Martinez C; Tsai CL; Locantore N; Atik M; Yohannes AM; Kao CC; Al-Azzawi H; Mohsin A; Wise RA; Foreman MG; Demeo DL; Regan EA; Make BJ; Boriek AM; Wiener LE; Hanania NA
    J Am Med Dir Assoc; 2017 Dec; 18(12):1063-1068. PubMed ID: 29169736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Prolonged Exacerbation Recovery in Chronic Obstructive Pulmonary Disease.
    Donaldson GC; Law M; Kowlessar B; Singh R; Brill SE; Allinson JP; Wedzicha JA
    Am J Respir Crit Care Med; 2015 Oct; 192(8):943-50. PubMed ID: 26151174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease.
    van Geffen WH; Tan DJ; Walters JA; Walters EH
    Cochrane Database Syst Rev; 2023 Dec; 12(12):CD011600. PubMed ID: 38054551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population.
    Pasquale MK; Sun SX; Song F; Hartnett HJ; Stemkowski SA
    Int J Chron Obstruct Pulmon Dis; 2012; 7():757-64. PubMed ID: 23152680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.